ETIDRONATE DIN 02347962
Health Canada record
| Active ingredient(s) | ETIDRONATE DISODIUM 200 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M05BA01 ETIDRONIC ACID |
| Original market date | |
| Current status date | 01-Sep-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Cobalt Pharmaceuticals Company — licence 100618, not currently licensed, last inspection rating C (2018-11-09).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ETIDRONATE DISODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02263866 | ACT ETIDROCAL | TEVA CANADA LIMITED | Tablet | ETIDRONATE DISODIUM 400 MG; CALCIUM (CALCIUM CARBONATE) 500 MG | Cancelled Post Market |
| 02248687 | ACT ETIDRONATE | TEVA CANADA LIMITED | Tablet | ETIDRONATE DISODIUM 400 MG | Cancelled Pre Market |
| 02248686 | ACT ETIDRONATE | TEVA CANADA LIMITED | Tablet | ETIDRONATE DISODIUM 200 MG | Cancelled Post Market |
| 02276852 | APO-ETIDRONATE | APOTEX INC | Tablet | ETIDRONATE DISODIUM 400 MG | Cancelled Pre Market |
| 02276844 | APO-ETIDRONATE | APOTEX INC | Tablet | ETIDRONATE DISODIUM 200 MG | Cancelled Pre Market |
| 02176017 | DIDROCAL | WARNER CHILCOTT CANADA CO | Kit; Tablet | ETIDRONATE DISODIUM 400 MG; CALCIUM (CALCIUM CARBONATE) 500 MG | Cancelled Post Market |
| 01908480 | DIDRONEL INJ 50MG/ML | MGI PHARMA INC. | Solution | ETIDRONATE DISODIUM 50 MG | Cancelled Post Market |
| 01997629 | DIDRONEL TAB 200MG | PROCTER & GAMBLE PHARMACEUTICALS CANADA INC | Tablet | ETIDRONATE DISODIUM 200 MG | Cancelled Post Market |
| 02353210 | ETIDROCAL | SANIS HEALTH INC | Tablet | ETIDRONATE DISODIUM 400 MG; CALCIUM (CALCIUM CARBONATE) 500 MG | Cancelled Post Market |
| 02347989 | ETIDROCAL | COBALT PHARMACEUTICALS COMPANY | Tablet | ETIDRONATE DISODIUM 400 MG; CALCIUM (CALCIUM CARBONATE) 500 MG | Cancelled Pre Market |
| 02347970 | ETIDRONATE | COBALT PHARMACEUTICALS COMPANY | Tablet | ETIDRONATE DISODIUM 400 MG | Cancelled Pre Market |
| 02247323 | MYLAN-ETI-CAL CAREPAC | MYLAN PHARMACEUTICALS ULC | Kit; Tablet | ETIDRONATE DISODIUM 400 MG; CALCIUM (CALCIUM CARBONATE) 500 MG | Cancelled Post Market |
| 02245330 | MYLAN-ETIDRONATE | MYLAN PHARMACEUTICALS ULC | Tablet | ETIDRONATE DISODIUM 200 MG | Cancelled Post Market |
| 02324199 | NOVO-ETIDRONATECAL | TEVA CANADA LIMITED | Kit; Tablet | ETIDRONATE DISODIUM 400 MG; CALCIUM (CALCIUM CARBONATE) 500 MG | Cancelled Post Market |
| 02358697 | NTP-ETIDRONATE CALCIUM | TEVA CANADA LIMITED | Tablet; Kit | ETIDRONATE DISODIUM 400 MG; CALCIUM (CALCIUM CARBONATE) 500 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 11198 | 2010-03-30 | Abbreviated New Drug Submission (ANDS) | Additional product name |
International API supply for ETIDRONATE DISODIUM
1 valid EDQM Certificates of Suitability from 1 holders. 0 active FDA Drug Master Files.
Request a quote for ETIDRONATE